Atlas Trials

Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults

Clinical trial NCT04501705 · RECRUITING

Trial details

NCT number
NCT04501705
Sponsor
Beijing Sanbo Brain Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Recurrent Atypical/malignant Meningioma
Start date
2020-08-18
Primary completion
2025-08-31
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.